Skip to content

School Studies Within the EuCARE Horizon Europe Research Project (EuCARE-SCHOOLS)

School Studies Within the EuCARE Horizon Europe Research Project (EUCARE-SCHOOLS Study)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05396040
Enrollment
3373
Registered
2022-05-27
Start date
2022-05-10
Completion date
2024-08-01
Last updated
2025-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STUDENTS

Brief summary

In this clinical trial, the aim is to determine if regular screening with pooled saliva tests (Lolli-Method) is useful to support school opening and to reduce clusters and attack rates in schools, compared with the standard of care (SoC) regular surveillance based on symptoms and contact tracing by public health departments.

Detailed description

In this clinical trial, it will be determined if regular screening with pooled saliva tests (Lolli-Method) is useful to support school opening and to reduce clusters and attack rates in schools, compared with the standard of care (SoC) regular surveillance based on symptoms and contact tracing by public health departments. A multicenter cluster randomised interventional study will be set-up to evaluate the efficacy and applicability of the Lolli-Methode. The study will enrol 440 classes (around 8800 students, teachers and other personnel) from 2 countries, randomised to Lolli-Methode or SoC. Samples from pools will be regularly collected and tested using PCR-based techniques. Test results will be combined with questionnaires filled in by children, parents and schools teachers and principals, concerning social distancing measures implemented and psychological impact of the preventive measures applied during the pandemic. A thorough data analysis will then be performed to understand the applicability of Lolli-Methode to reduce SARS-COV-2 transmission in schools, including incidence, attack rates and cluster analysis. On the other hand, mobility changes and psychological outcomes will be analysed and compared with variables related to SARS-COV-2 transmission. By the end of this study, it will be identified and characterised the applicability of the Lolli-Methode for SARS-COV-2 surveillance, as well as the impact of pandemic preventive measures on children. An ancillary observational study will be carried out on a different population of schools to study the prevalence of SARS-COV-2, frequencies and size of clusters and attack rates in schools, compared with those of previous waves; to compare the effectiveness of different preventive measures adopted in different schools; to investigate psychological issues in students and teachers related to the pandemic's containment measures.

Interventions

PROCEDURELOLLI METHODE

WEEKLY SCREENING WITH POOLED SALIVA PCR TEST

Sponsors

University of Salento
CollaboratorOTHER
Istituto Europeo di Oncologia
CollaboratorOTHER
University of Milan
CollaboratorOTHER
University of Lisbon
CollaboratorOTHER
University of Cologne
CollaboratorOTHER
Hospital Regional de Alta Especialidad Dr. Juan Graham Casasus
CollaboratorOTHER
Euresist Network GEIE
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

The study will enrol 440 classes (around 8800 students, teachers and other personnel) from 2 countries, randomised to Lolli-Methode or SoC. Samples from pools will be regularly collected and tested using PCR-based techniques.

Eligibility

Sex/Gender
ALL
Age
5 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Kindergartens and school-age children from public or private schools . * Enrolled children may be students of classes that have expressed their consent to participate * School personnel of participating schools * Householders of participating children * Informed consent (for minors the informed consent will be signed by parents or legal guardians) . * For minors: will to participate.

Exclusion criteria

* No informed consent by schools or children, or the adult participant * Suspicion of acute COVID-19 infection: In case of unknown respiratory infection, no presence of symptoms for at least 48 hours. In case of confirmed SARS-COV-2 infection: inclusion at the earliest 21 days from PCR-positive diagnosis after the onset of potential symptoms and no presence of symptoms for at least 48 hours (according to Standard of Care).

Design outcomes

Primary

MeasureTime frameDescription
Frequencies of clustersup to 18 monthsFrequencies of clusters in classrooms in which pooled saliva tests (Lolli-Method) are performed in association with standard contact-tracing protocols, compared with classrooms in which SoC protocols are applied.
Number of participating classesup to 18 monthsNumber of classes and of students in the classes that accept to participate in the Lolli-Methode study, if asked, during time

Secondary

MeasureTime frameDescription
Transmission/prevalence of SARS-COV-2 in schools by variantsup to 18 monthsTransmission/prevalence of SARS-COV-2 in schools by variants, by assessing the proportion of students/staff with positive SARS-COV-2 test identified by pooled saliva tests (Lolli-Method)
Psychological status of childrenup to 18 monthsPsychological status of children during coronavirus pandemics: negative and positive feeling during confinement, worries and expectations about school resumption as evaluated by questionnaires.

Countries

Italy, Mexico, Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026